STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31

STERIS plc

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$221.97−0.69 (-0.31%)

Close on Oct 19, 2026

Market cap: $21.73B
P/E (TTM): 27.1
Dividend yield: 1.11%

STERIS plc income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31
Revenue	5,936	5,460	5,139	4,536	4,223	3,108	3,031	2,782	2,620	2,613
Cost of Revenue	3,309	3,057	2,921	2,556	2,340	1,764	1,711	1,607	1,527	1,587
Gross Profit	2,627	2,403	2,218	1,981	1,883	1,343	1,320	1,175	1,093	1,026
Research & Development	113	108	104	98	87	66	66	63	61	59
Selling, General & Admin	1,408	1,334	1,252	1,091	1,318	731	717	670	632	682
Advertising Expenses	20	20	26	22	16	6.80	13	11	11	13
Operating Expenses	1,525	1,536	1,382	1,190	1,405	795	783	764	693	800
Operating Income	1,102	867	836	791	478	548	537	411	400	226
Interest Expense	61	86	144	108	89	37	40	45	51	45
Other Non-Operating Income	-54	-70	-133	-111	-111	-31	-38	-42	-45	-42
Merger & Restructuring Charges	3.40	62	44	0.49	0.05	-3.03	3.14	41	0.10	0.22
Asset Impairment Charges	–	0	0	491	0	0	–	0	0	58
Gain (Loss) on Investments	0.20	0.90	1.06	0	0	0.59	-3.58	-2.73	–	–
Gain (Loss) on Sale of Assets	-3.60	-5.70	-25	-22	-15	1.98	0.17	-0.92	-2.58	-0.76
Pretax Income	1,047	796	703	680	367	518	499	369	355	185
Income Tax Expense	262	185	150	124	82	121	91	64	63	74
Income from Continuing Operations	785	612	553	556	284	–	–	–	–	–
Income from Discontinued Operations	0	4.50	-173	-450	-42	–	–	–	–	–
Net Income incl. Noncontrolling Interests	785	616	380	106	243	397	408	305	292	111
Minority Interest in Earnings	2.80	1.40	1.80	-1.22	-1.02	-0.53	0.20	1.03	0.71	0.67
Net Income	782	615	378	107	244	397	408	304	291	110
EPS (Basic)(per share)	7.97	6.24	3.83	1.07	2.50	4.66	4.81	3.59	3.42	1.29
EPS (Diluted)(per share)	7.93	6.20	3.81	1.07	2.48	4.63	4.76	3.55	3.39	1.28
Shares Outstanding (Basic, Weighted)(shares)	98	99	99	100	98	85	85	85	85	85
Shares Outstanding (Diluted, Weighted)(shares)	99	99	99	100	98	86	86	85	86	86
Dividend per Share(per share)	2.46	2.23	2.03	1.84	1.69	1.57	1.45	1.33	1.21	1.09
EBITDA	1,588	1,343	1,401	1,344	1,031	768	734	637	578	414

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 44.4%
Operating margin: 18.9%
Net margin: 13.3%
Return on equity, FY2026: 11.3%

Financial strength

Current ratio: 1.91
Debt to equity: 0.26
Debt to assets: 17.6%
Cash to current liabilities: 37.6%

Valuation

P/E ratio: 27.1
Price to sales: 3.60
Price to book: 3.02
Dividend yield: 1.11%